Unicon Optical Co., Ltd. (4150) Fair Value & Analysis

Healthcare · TW · Market cap 692M TWD (≈ $21.9M) · ISIN TW0004150008

What is Unicon Optical Co., Ltd. really worth?

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

What matters now

• The large discount to fair value meets weak quality (32/100). That raises the risk this is a value trap rather than a bargain.
• The price is below even our cautious bear case (1.64 TWD). The market is more pessimistic than our downside scenario.
• The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
• A fairly wide model range (1.64 TWD to 3.29 TWD) leaves room in how you read the outcome.

Price vs Fair Value (5 years)

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 19, 2026.

How to read this chart

60‑month range 1.25 TWD – 25.65 TWD · fair‑value band 1.64 TWD – 3.29 TWD · the 1.59 TWD price screens below the 2.20 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 19, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Unicon Optical Co., Ltd. (4150) currently trades at 1.59 TWD, while our model-based Fair Value estimate is 2.20 TWD, implying the stock looks roughly 27.7% undervalued today. The Quality Score stands at 32/100 (below-average quality), in the Healthcare sector. How firm this estimate is: it rests on 1 models at a data quality of 95/100, which puts the evidence level at low.

Over the trailing twelve months, Unicon Optical Co., Ltd. generated revenue of 641M TWD at a net margin of −42.7%. Revenue declined 23.4% year over year. It earns a return on equity of −43.7%. Net debt stands at 127M TWD. Fundamentals as of Aug 19, 2026

Our scenario range runs from 1.64 TWD (bear case) to 3.29 TWD (bull case); at 1.59 TWD, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Healthcare peers we cover trades at −46% fair-value upside, at 38%, 4150 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.

Key figures & financial health

Quality Score breakdown

About the company

Unicon Optical Co., Ltd. researches, develops, designs, manufactures, and sells contact lenses in Taiwan. The company offers basic blue tint, color, and silicon hydrogel lenses under the brand name UNICON. The company was founded in 1992 and is headquartered in Hsinchu City, Taiwan.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Unicon Optical Co., Ltd. reported revenue of 641M TWD in FY2025 versus 898M TWD in FY2021, a compound −8.1%/yr. Reported net income was −274M TWD in FY2025.

Watch 4150: get an alert when its fair value changes →

Peer Group

Medical Instruments & Supplies · 194 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Valuation Multiples vs Medical Instruments & Supplies median · lower = cheaper

Strength profile in five axes (Snowflake)

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Aug 19, 2026).

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

Discover tools

Frequently asked questions